Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer

Fig. 1

Circulating miR-141 is aberrantly upregulated in patients with SCLC. A. The relative expression of miR-141 was higher in plasma exosomes from SCLC patients than that in those from healthy volunteers. B. The level of plasma exosomal miR-141 was particularly high in stage IV SCLC patients. C. SCLC patients with extensive disease had a higher expression of miR-141 in plasma exosomes than whom with limited disease. D. The relative expression of miR-141 was higher in serum samples from SCLC patients than that in those from healthy volunteers. E. The expression of circulating miR-141 was particularly high in the serum of stage IV SCLC patients. F. SCLC patients with extensive disease had a higher expression of miR-141 in serum than whom with limited disease. N, normal; T, tumor; I, stage I; II, stage II; III, stage III; IV, stage IV; LD, limited disease; ED, extensive disease

Back to article page